The effect of diclofenac acid (Voltaren) on bleomycin-induced pulmonary fibrosis in hamsters.
Bleomycin is an anti-neoplastic compound which produces a time- and dose-dependent pulmonary fibrosis. The mechanisms which cause this fibrosis are not known. However, the ability of bleomycin to modulate prostaglandin synthesis, degradation and circulating levels appears to be central to the fibrosis. Previous studies, which have attempt to modulate bleomycin-induced fibrosis by prevention of prostaglandin synthesis have conflicting results. Therefore, the present study was designed to determine the effects of diclofenac acid, a nonsteroidal anti-inflammatory compound, on the development of bleomycin-induced pulmonary fibrosis. Diclofenac acid pretreatment and daily injections prevented lung collagen accumulation after intratracheal bleomycin. In addition diclofenac acid treatment resulted in significantly lower lung collagen level after intratracheal bleomycin at 14 and 21 days when compared with bleomycin alone. These data indicate that diclofenac acid treatment inhibits bleomycin-induced lung fibrosis possible through the prevention of prostaglandins synthesis.
Chandler
D B
DB
Department of Medicine, University of Alabama, Birmingham 35294.
Young
K
K
D000818:Animals; D001761:Bleomycin / Q000494:pharmacology*; D001992:Bronchoalveolar Lavage Fluid; D003094:Collagen / Q000378:metabolism; D006224:Cricetinae; D004008:Diclofenac / Q000494:pharmacology*; D008168:Lung / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000517:prevention & control*
D011453:Prostaglandins; D001761:Bleomycin; D004008:Diclofenac; D003094:Collagen